These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23414447)

  • 21. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.
    Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Buendía-Eisman A; Naranjo-Sintes R
    J Am Acad Dermatol; 2010 Sep; 63(3):420-9. PubMed ID: 20619491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.
    Ingelsson E; Pencina MJ; Tofler GH; Benjamin EJ; Lanier KJ; Jacques PF; Fox CS; Meigs JB; Levy D; Larson MG; Selhub J; D'Agostino RB; Wang TJ; Vasan RS
    Circulation; 2007 Aug; 116(9):984-92. PubMed ID: 17698726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome is associated with and predicted by resting heart rate: a cross-sectional and longitudinal study.
    Jiang X; Liu X; Wu S; Zhang GQ; Peng M; Wu Y; Zheng X; Ruan C; Zhang W
    Heart; 2015 Jan; 101(1):44-9. PubMed ID: 25179964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome and risk of age-related cataract over time: an analysis of interval-censored data using a random-effects model.
    Ghaem Maralani H; Tai BC; Wong TY; Tai ES; Li J; Wang JJ; Mitchell P
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):641-6. PubMed ID: 23258144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels.
    Onat A; Ozhan H; Erbilen E; Albayrak S; Küçükdurmaz Z; Can G; Keleş I; Hergenç G
    Int J Cardiol; 2009 Jun; 135(2):211-7. PubMed ID: 18582961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population.
    Andreadis EA; Tsourous GI; Tzavara CK; Georgiopoulos DX; Katsanou PM; Marakomichelakis GE; Diamantopoulos EJ
    Am J Hypertens; 2007 May; 20(5):558-64. PubMed ID: 17485022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma copeptin, a unifying factor behind the metabolic syndrome.
    Enhörning S; Struck J; Wirfält E; Hedblad B; Morgenthaler NG; Melander O
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1065-72. PubMed ID: 21490073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study.
    Hoseini SM; Kalantari A; Afarideh M; Noshad S; Behdadnia A; Nakhjavani M; Esteghamati A
    Metabolism; 2015 Apr; 64(4):527-38. PubMed ID: 25633268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.
    Puenpatom RA; Victor TW
    Postgrad Med; 2009 Nov; 121(6):9-20. PubMed ID: 19940413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.
    Athyros VG; Elisaf MS; Alexandrides T; Achimastos A; Ganotakis E; Bilianou E; Karagiannis A; Liberopoulos EN; Tziomalos K; Mikhailidis DP;
    Angiology; 2012 Jul; 63(5):358-66. PubMed ID: 22007026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous metabolic syndrome risk score for predicting cardiovascular disease in the Chinese population.
    Kang GD; Guo L; Guo ZR; Hu XS; Wu M; Yang HT
    Asia Pac J Clin Nutr; 2012; 21(1):88-96. PubMed ID: 22374565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trajectories of entering the metabolic syndrome: the framingham heart study.
    Franco OH; Massaro JM; Civil J; Cobain MR; O'Malley B; D'Agostino RB
    Circulation; 2009 Nov; 120(20):1943-50. PubMed ID: 19884471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis.
    Lee M; Saver JL; Huang WH; Chow J; Chang KH; Ovbiagele B
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):675-83. PubMed ID: 20923994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study.
    Keihani S; Hosseinpanah F; Barzin M; Serahati S; Doustmohamadian S; Azizi F
    Atherosclerosis; 2015 Feb; 238(2):256-63. PubMed ID: 25540856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity, physical activity and the development of metabolic syndrome: the Atherosclerosis Risk in Communities study.
    Cheriyath P; Duan Y; Qian Z; Nambiar L; Liao D
    Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):309-13. PubMed ID: 20300002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical analysis of the relationship between cystatin C and metabolic syndrome in the elderly.
    Liu P; Sui S; Xu D; Xing X; Liu C
    Rev Port Cardiol; 2014; 33(7-8):411-6. PubMed ID: 25155006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.